Christian Mueller

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Replacement Therapy

Smoking Cessation

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Forster, Irene Brana, Antonio L Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Antonio Peguero, Matthew G Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Martin Forster, Irene Brana, Antonio L Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Antonio Peguero, Matthew G Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Eftilagimod alpha (soluble LAG-3 protein) combined with pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Hans P M W Wildiers, Anne C Armstrong, Eveline Cuypere, Florence Dalenc, Luc Dirix, Stephen Chan, Frederic Marmé, Carolina P Schröder, Jens Huober, Fran Ois P Duhoux, Peter Vuylsteke, Agnes Jager, Etienne G C Brain, Sherko Kuemmel, Zsuzsanna Pápai, Catharina Willemien Menke-van der Houven van Oordt, Luca Perjesi, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)